Analysen zu SAFRAN S.A.
| 19.03.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 08.03.24 | SAFRAN Neutral | UBS AG | |
| 06.03.24 | SAFRAN Neutral | UBS AG | |
| 04.03.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 26.02.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 21.02.24 | SAFRAN Hold | Deutsche Bank AG | |
| 16.02.24 | SAFRAN Halten | DZ BANK | |
| 16.02.24 | SAFRAN Hold | Deutsche Bank AG | |
| 15.02.24 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.02.24 | SAFRAN Neutral | UBS AG | |
| 15.02.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 15.02.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 16.01.24 | SAFRAN Neutral | UBS AG | |
| 15.01.24 | SAFRAN Hold | Deutsche Bank AG | |
| 12.01.24 | SAFRAN Overweight | Barclays Capital | |
| 09.01.24 | SAFRAN Overweight | Barclays Capital | |
| 11.12.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 08.12.23 | SAFRAN Hold | Deutsche Bank AG | |
| 06.12.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 20.11.23 | SAFRAN Buy | Goldman Sachs Group Inc. | |
| 13.11.23 | SAFRAN Overweight | Barclays Capital | |
| 06.11.23 | SAFRAN Neutral | UBS AG | |
| 01.11.23 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.10.23 | SAFRAN Neutral | UBS AG | |
| 27.10.23 | SAFRAN Hold | Jefferies & Company Inc. | |
| 27.10.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 27.10.23 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.10.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 13.10.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 28.09.23 | SAFRAN Neutral | UBS AG | |
| 07.09.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 06.09.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 10.08.23 | SAFRAN Buy | UBS AG | |
| 08.08.23 | SAFRAN Buy | Deutsche Bank AG | |
| 03.08.23 | SAFRAN Overweight | Barclays Capital | |
| 28.07.23 | SAFRAN Buy | Deutsche Bank AG | |
| 27.07.23 | SAFRAN Buy | UBS AG | |
| 27.07.23 | SAFRAN Hold | Jefferies & Company Inc. | |
| 24.07.23 | SAFRAN Buy | UBS AG | |
| 14.07.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 14.07.23 | SAFRAN Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.07.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 10.07.23 | SAFRAN Buy | UBS AG | |
| 07.07.23 | SAFRAN Hold | Jefferies & Company Inc. | |
| 07.07.23 | SAFRAN Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.06.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 22.06.23 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.06.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 19.06.23 | SAFRAN Hold | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 03.12.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Sanofi Sell | Deutsche Bank AG | |
| 03.12.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | FedEx Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Siemens Healthineers Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Philips Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Stellantis Equal Weight | Barclays Capital | |
| 03.12.24 | HUGO BOSS Buy | UBS AG | |
| 03.12.24 | Volkswagen Overweight | Barclays Capital | |
| 03.12.24 | Valeo Equal Weight | Barclays Capital | |
| 03.12.24 | Michelin Underweight | Barclays Capital | |
| 03.12.24 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Continental Overweight | Barclays Capital | |
| 03.12.24 | Porsche Automobil vz. Underweight | Barclays Capital | |
| 03.12.24 | AIXTRON Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.12.24 | Mercedes-Benz Group Underweight | Barclays Capital | |
| 03.12.24 | Porsche Overweight | Barclays Capital | |
| 03.12.24 | BMW Equal Weight | Barclays Capital | |
| 03.12.24 | KION GROUP Buy | UBS AG | |
| 03.12.24 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 03.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 03.12.24 | Valeo Neutral | UBS AG | |
| 03.12.24 | easyJet Buy | UBS AG | |
| 03.12.24 | EssilorLuxottica Neutral | UBS AG | |
| 03.12.24 | Volkswagen Sell | UBS AG | |
| 03.12.24 | Mercedes-Benz Group Neutral | UBS AG | |
| 03.12.24 | Porsche Neutral | UBS AG | |
| 03.12.24 | BMW Buy | UBS AG | |
| 02.12.24 | Schneider Electric Overweight | JP Morgan Chase & Co. | |
| 02.12.24 | Hennes & Mauritz AB Buy | UBS AG | |
| 02.12.24 | BMW Equal Weight | Barclays Capital | |
| 02.12.24 | Porsche Overweight | Barclays Capital | |
| 02.12.24 | BASF Buy | Baader Bank | |
| 02.12.24 | JENOPTIK Halten | DZ BANK | |
| 02.12.24 | Merck Kaufen | DZ BANK | |
| 02.12.24 | Siemens Healthineers Neutral | UBS AG | |
| 02.12.24 | Novo Nordisk Neutral | UBS AG | |
| 02.12.24 | K+S Neutral | JP Morgan Chase & Co. | |
| 02.12.24 | Covestro Neutral | JP Morgan Chase & Co. | |
| 02.12.24 | BASF Neutral | JP Morgan Chase & Co. | |
| 02.12.24 | WACKER CHEMIE Neutral | JP Morgan Chase & Co. | |
| 02.12.24 | Evonik Overweight | JP Morgan Chase & Co. | |
| 02.12.24 | LANXESS Underweight | JP Morgan Chase & Co. | |
| 02.12.24 | Brenntag Underweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.